Sun Pharma Attacks Incyte Patents In Alopecia Drug Battle
An Indian generic-drug maker has asked a London court to nix Incyte's patents for a blockbuster drug treating autoimmune conditions, as the rival plans to launch a hair loss treatment that...To view the full article, register now.
Already a subscriber? Click here to view full article